Clinical Trial Update: Intranasal Insulin: A Novel Treatment for Gulf War Multisymptom Illness [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating intranasal insulin as a novel treatment for Gulf War multisymptom illness (chronic multisymptom illness) in veterans.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multisymptom Illness

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: Bronx Veterans Medical Research Foundation, Inc | Conditions: Chronic Multisymptom Illness in Gulf War Veterans | Phase 2 | Status: UNKNOWN